AbbVie’s hepatitis C drug gets European approval for sale
January 16, 2015 at 07:54 AM EST
AbbVie has said European regulators approved the sale of the company’s hepatitis C treatment, a combination of Viekirax and Exviera that is already approved in the U.S.
